E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer

Citation
Jm. Coulson et al., E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer, BIOCHEM J, 344, 1999, pp. 961-970
Citations number
52
Categorie Soggetti
Biochemistry & Biophysics
Journal title
BIOCHEMICAL JOURNAL
ISSN journal
02646021 → ACNP
Volume
344
Year of publication
1999
Part
3
Pages
961 - 970
Database
ISI
SICI code
0264-6021(199912)344:<961:EMWTHV>2.0.ZU;2-P
Abstract
[Arginine]vasopressin (AVP) is a neuropeptide physiologically synthesized i n the hypothalamus but pathologically expressed by small-cell lung cancer ( SCLC). A minimal 65 bp AVP promoter can restrict basal activity to SCLC in vitro, but a 199 bp fragment directs 5-fold higher expression in SCLC [Coul son, Stanley and Well (1999) Br. J. Cancer 80, 1935-1944]. Several predicte d E-box motifs occur within the 199 bp fragment, and we now describe an enh ancer which contributes to AVP promoter tumour-specificity in some cell lin es. The deletion of two adjacent E-boxes (-157 to -131) resulted in an appr ox. 70% loss of reporter gene expression in a SCLC line (Lu-165) with high endogenous AVP production. Using a series of AVP promoter deletion construc ts and site-directed mutagenesis, we show that both these E-box sites were required for enhancer function, whereas mutation of an adjacent AP-1 site h ad no effect on the promoter activity. Electrophoretic-mobility-shift analy sis indicated that, although both the predicted E-box motifs bound specific complexes, only one appeared to function as a strong E-box which binds bas ic helix-loop-helix (bHLH) factors. This motif formed a complex in lung tum our-cell extracts, which was particularly strongly bound in Lu-165, and was competed for by a characterized E-box motif from the preprotachykinin A pr omoter. Antibody supershifts indicate that this complex is a heterodimer of upstream stimulatory factor (USF)-1 and USF-2. Non-bHLH complexes weakly b ound the second potential E-box motif in a SCLC-specific manner. These comp lexes were not recognized by the bHLH antibodies and remain unidentified; h owever, they were detected in seven of eight SCLC cell lines and not in fou r control lines. We postulate that there is a co-operative and complex inte raction between an E-box and an adjacent site constituting a SCLC-specific enhancer within the AVP proximal promoter.